Alterations
in neurofilaments are a common occurrence in neurons of the human nervous system during aging and diseases associated with aging. Such pathologic changes may be attributed to species-specific properties of human neurofilaments as well as cell-type-specific regulation of this element of the cytoskeleton.
The development of transgenic animals containing human neurofilament subunits offers an opportunity to study the effects of aging and other experimental conditions on the human-specific form of these proteins in a rodent model. The present study shows that mice from the transgenic line NF(M)27, which express the human midsized neurofilament subunit at low levels (2-25% of the endogenous NF-M), develop neurofilamentous accumulations in specific subgroups of neurons that are age dependent, affecting 78% of transgenic mice over 12 months of age. Similar accumulations do not occur in age-matched, wild-type littermates or in 3-month-old transgenic mice. In 12-month-old transgenic mice, somatic neurofilament accumulations resembling neurofibrillary tangles were present predominantly in layers Ill and V of the neocortex, as well as in select subpopulations of subcortical neurons. Intraperikaryal, spherical neurofilamentous accumulations were particularly abundant in cell bodies in layer II of the neocortex, and neurofilament-containing distentions of Purkinje cell proximal axons occurred in the cerebellum.
These pathological accumulations contained mouse as well as human NF subunits, but could be distinguished by their content of phosphorylation-dependent NF epitopes. These cytoskeletal alterations closely resemble the cell-type-specific alterations in neurofilaments that occur during normal human aging and in diseases associated with aging, indicating that 0 1994 Society for Neuroscience 0270-6474/94/145603-10$05.00/O these transgenic animals may serve as models of some aspects of the pathologic features of human neurodegenerative diseases.
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Perturbations of neurofilaments (NFs) is a common pathologic feature of a variety of human neurodegenerative diseases, particularly those related to aging. These cytoskeletal elements have been shown to contribute to the formation of the neurofibrillary changes observed during normal human aging (Vickers et al., 1992) as well as in Alzheimer's disease (Dahl et al., 1982; Perry et al., 1985; Cork et al., 1986; Haugh et al., 1986; Miller et al., 1986; Lee et al., 1988b; Metuzals et al., 1988; Mulvihill and Perry, 1989; Zhang et al., 1989; Cammarata et al., 1990; Schmidt et al., 1990; Gheuns et al., 1991; Vickers et al., 1992) Lewy body-type dementias (Sima et al., 1986; Schmidt et al., 1991; Pollanen et al., 1992 ), Pick's disease (Perry et al., 1987; Ulrich et al., 1987) Parkinson's disease (Goldman et al., 1983; Forno et al., 1986; Bancher et al., 1989; Schmidt et al., 199 1; Galloway et al., 1992) and amyotrophic lateral sclerosis (Manetto et al., 1988; Munoz et al., 1988; Toyoshima et al., 1989) . Animal models of neurofilamentous pathology would facilitate analysis of the cellular and functional consequences of this type of cytoskeletal alteration. Established experimental models have included intoxication of animals with substances such as colchitine, aluminum, &P'-iminodipropionitrile, ethanol, acrylamide, and hexacarbons. Studies have also shown that aging and certain diseases in nonhuman animals result in neurofilamentous alterations in particular groups of neurons (van den Bosch de Aguilar and Goemaere-Vanneste, 1984; Cork et al., 1988a,b) with important similarities and differences to the neuropathologic hallmarks described in the above human diseases. Interspecies variability in the extent of cytoskeletal pathology may be due to molecular differences between homologous neuronal intermediate filament proteins. Among the three subunits that comprise the coexpressed class of neuronal intermediate filaments known as the NF "triplet," the middle-molecularweight subunit, NF-M, is of particular interest since there are important molecular differences in the homologous subunit between species. For example, the human NF-M subunit contains a tandem array of 12 near-perfect repeats, each encoding a lysine-serine-proline-valine (KSPV) sequence (Myers et al., 1987) , and it has been shown that this series of KSPVs can be phos- Table 1 . Neuronal markers Heterozygous transgenic and wild-type littermate control mice were bred on a mixed C,,B1/6J, DBA/2J background and the presence of the transgene was determined for each individual by PCR analysis of blood or tail DNA. This study used 3-and 12-month-old heterozygous and wild-type littermate control mice. A limited analysis was also performed on tissue from the line's founder mouse, aged 27 months, and from other transgenic and wild-type mice between the ages of 4 and 8 months.
Immunohistochemical analysis. Under anesthesia (ketamine/xylazine), mice were perfused intracardially initially with a 0.1 M phosphatebuffered saline solution followed by 4% paraformaldehyde in phosphatebuffered saline. The brain and spinal cord were removed and postfixed in the paraformaldehyde solution for 4 hr. Thirty-micrometer cryostat sections were collected for immunohistochemistry, including sagittal and coronal sections of the right and left halves, respectively, of the brain rostra1 to the level of the inferior colliculus, along with coronal sections of the remaining brainstem and cerebellum and transverse sections of the spinal cord.
A variety ofantibodies to NF proteins and other pathological markers (Table 1) were visualized using either species-specific Vectastain ABC immunoperoxidase kits (Vector Lab., Burlingame, CA) or secondary antibodies conjugated to the fluorophores fluorescein isothiocyanate (FITC) or Texas red (Vector and Amersham, Arlington Heights, IL). Secondary antibodies were free of undue cross-reactivity. Mouse monoclonal antibodies SMI32 and SM13 10, which respectively recognize nonphosphorylated or phosphorylated epitopes on both human and mouse NF-M and NF-H subunits (Lee et al., 1988a; Zhang et al., 1989) , were obtained from Sternberger Monoclonals Inc. (Baltimore, MD); RM0108, a mouse monoclonal antibody that recognizes partially phosphorylated mouse NF-M Pleasure et al., 1990) , and H014, a rat monoclonal antibody that labels phosphorylated human NF-M (Lee et al., , 1988a Pleasure et al., 1990) phorylated and forms the major antigenic site of the NF-M subunit (Geisler et al., 1987; Lee et al., 1988a) . Rodent and avian NF-M subunits, while otherwise very similar to their human counterpart, contain only one or two degenerate KSPV repeats (Levy et al., 1987; Napolitano et al., 1987; Zopf et al., 1987) . Furthermore, the squid neurofilament gene, which is thought to be more primitive than the vertebrate gene, encodes an NF-M without KSPV repeats (Way et al., 1992) . These observations suggest that the multiple repeats of this motif are a phylogenetically recent addition to the NF-M protein, occurring after the divergence of rodent and primate orders. These differences may be important pathologically since abnormal phosphorylation has been suggested to be a general mechanism leading to cytoskeletal alterations in human disease, and so the differences in organization of this phosphorylation site repeat region in the NF-M carboxy terminus may be contributing to the propensity of NFs to undergo disease/age-related alterations. Indeed, phosphorylation of the repeat-containing region of human NF-M in the presence of Ca*+ or A13+ produces dramatic conformational changes that lead to NF aggregation, including cross-linking and a high content of P-pleated sheet structure (HolEsi et al., 1992) . The production of transgenic mice expressing human neurofilament proteins (Charron et al., 1992; Lee et al., 1992; C&C et al., 1993) presents an opportunity to study the specific human isoform of these cytoskeletal proteins within a rodent model that is amenable to aging and experimental studies. The previously characterized NF(M)27 transgenic mouse line is particularly useful as this mouse expresses the human NF-M subunit at levels substantially lower (2-25%) than those of the native murine NF-M, but with the human subunit contributing toward the formation of normal filaments in young animals . Using multiple immunohistochemical markers and electron microscopy, we have found that these animals exhibit a striking age-associated pathology involving the accumulation of neurofilamentous material into pathologic structures that not only resemble those found in human diseases but also display similar patterns of cellular vulnerability that may be linked to cell-type-specific regulation of NF protein content and metabolism.
Materials and Methods
Animals. The NF(M)27 transgene contains an 8.5 kb DNA fragment that includes the human NF-M gene and an 2.8 kb upstream promoter sequence. Mice heterozygous for the NF(M)27 transgene express the human protein in the CNS and PNS, with immunoelectron microscopy demonstrating that the human NF-M protein coassembles into filaments with the endogenous mouse NF proteins .
Results
Immunolabeling with antibodies that recognize nonphosphorylated (SM132) and phosphorylated (SM13 10) epitopes on both mouse and human NF-M and NF-H subunits (Lee et al., 1988a; Zhang et al., 1989) was present in the nervous system of both transgenic and wild-type mice at 3 and 12 months of age. SM132 preferentially labeled neuronal perikarya and dendrites with minimal axonal labeling ( Fig. 1 A) , whereas SM13 10 preferentially labeled axons. Another antibody, RM0108, that recognizes partially phosphorylated NF-M mouse epitopes but not human NF proteins Pleasure et al., 1990) labeled cell bodies, dendrites, and axons in transgenic and wildtype mice of both ages. Specific subpopulations of neurons were labeled with RMO 108 and SM132 throughout the mouse brain in a pattern that was consistent with the restricted distribution of the neurofilament triplet proteins to particular neuronal subtypes (reviewed in Vickers and Costa, 1992a) . Labeling with the antibody specific for human NF-M phosphorylated epitopes (H014) (Lee et al., , 1988a Pleasure et al., 1990) was present in axons of transgenic animals as previously described , whereas no labeling was present in wild-type mice. SM132 and RM0108 also intensely labeled neurofilamentous accumulations (NFAs) present in the nervous system of six of the eight 12-month-old transgenic animals examined, but not in five age-matched wild-type mice or in 50 3-month-old transgenie mice. The same pathologic structures were visualized equally well with immunofluorescence and immunoperoxidase cytochemical procedures. The NFAs consisted of two basic morphological types: (1) tangle-like perikaryal accumulations surrounding or adjacent to the nucleus and tapering off into the primary dendritic processes, and (2) spherical or ellipsoidal structures, varying in diameter from approximately 1 to 10 pm. The spherical NFAs were particularly prevalent in the neocortex (Figs. l&H, 2), with fewer of these inclusions in the amygdala, thalamus, hippocampus (Fig. 34 , and cerebellum, whereas tangle-like NFAs were observed in neocortex (Figs. E-D, 24 but were also present in the hippocampus (Fig. 34 , entorhinal cortex, amygdala, thalamus (Fig. 38) , superior colliculus, pontine nuclei, deep cerebellar nuclei, gracile nucleus, cuneate nucleus, inferior olivary nucleus, some reticular neurons, and cranial nerve nuclei such as the cochlear, vestibular, trigeminal motor, facial motor, and hypoglossal nuclei (Fig. 3D,E) .
With regard to the neocortex, tangle-like NFAs were distributed primarily in layers III and V, whereas the relatively more abundant spherical NFAs were present principally in layer II and, to a lesser degree, layer IV (Figs. 1 B-H, 2 ). Both the spherical and tangle-like NFAs were predominantly located in somatosensory and frontal neocortex, including the motor areas, with relatively few of these NFAs occurring in visual cortex. While the pattern of NFA formation in the cortex was qualitatively similar between these animals, there was considerable variation in the number of these structures present in a given area. For example, the density of spherical NFAs in layers II andIII'ofsomatosensorycortex was60.0(+6.6 SE), 51.0(+9.9), and 19.4 (k4.6) per millimeter of cortical traverse in the three most severely affected transgenic animals to less than five per millimeter in the three other animals showing these cytoskeletal alterations. Similarly, tangle-like NFAs varied from 15-20 per sagittal section in the severely affected animals to one or two per section in the least affected animals. Cortical sections from the 12-month-old transgenic mice labeled with SM132 or RM0108 and counterstained with either DAPI or ethidium bromide demonstrated that the great majority of the tangle-like and spherical NFAs occurred inside cell bodies (Fig. lE,F) . The cortical spherical NFAs were labeled by SM132, RMO 108, SM13 10, and H014, indicating the presence of mouse and human NF-M, as well as nonphosphorylated and phosphorylated epitopes (Table 2 ). Double labeling verified that the phosphorylated form of the transgenic human protein, visualized with H014, was present in a large subset of the spherical NFAs labeled with either SM132 or RMO 108 (Fig. 1 G, H) . Tangle-like NFAs were also vividly labeled by SM132, indicating the presence of abundant nonphosphorylated NF-M and/or NF-H, but they differed from the spherical NFAs in that they were seldom (<5%/o) labeled with antibodies (SM1310 and H014) to either mouse or human phosphorylation-dependent epitopes ( Table   Table 2 2). Thus, in contrast to the tangle-like NFAs, many of the spherical NFAs contained phosphorylation-dependent NF protein epitopes normally found in axons.
In the cerebellum of the 12-month-old transgenic mice, NFAs labeled with NF antibodies were present in less than 1% of Purkinje cell bodies (Fig. 3C, Table 2 ). Some Purkinje cells demonstrated swellings of the proximal axon that were labeled with SM132, RM0108, H014, and SM1310. No NFAs were observed within other cell types of cerebellar cortex.
Ultrastructural analysis of the frontal pole of a 12-month-old transgenic animal confirmed that many neurons in the superficial layers contained perikaryal accumulations of ultrastructurally identifiable neurofilaments that were likely to correspond to the spherical NFAs observed with immunocytochemical methods. These NFAs consisted of bundles of filaments that were often interconnected by fine filamentous cross-bridges (Fig.  4) . Other cytoplasmic elements, such as mitochondria and tubular and vesicular membranes, as well as granular material were often detected within the NFAs.
No aberrant neurofilamentous structures were detected with these NF antibodies in the spinal cord of any of the animals, which is consistent with the low degree of expression of the human protein in this region in this line . Staining with thioflavine S or immunolabeling with markers such as Alz50 and antibodies to /3-amyloid and ubiquitin was not present in NFAs, or in any other structures specific to the 12-month-old transgenic animals.
As noted above in the case of the relative density of NFAs in the cortex of the older transgenic mice, individual variation occurs in the amount of neurofibrillary pathology. Furthermore, two of the eight 12-month-old transgenic animals lacked NFAs, although labeling with HO14 confirmed the presence of the human protein within axonal pathways characteristic of other animals ofthe NF(M)27 line . Abundant tanglelike and spherical NFAs, labeled with SM132 and stained with silver impregnation methods, were also present in cortical sections of the 27-month-old NF(M)27 founder, but NFAs have not been detected in a large group (50) of transgenic mice less than 3 months old. The presence of pathologic features at intermediate ages was variable, with spherical and tangle-like NFAs being observed in a 4.6-month-old transgenic animal but not in two 8-month-old transgenic mice examined.
Discussion
The data presented in this report demonstrate that the neurofilamentous inclusions in NF(M)27 mice are linked to the presence of the human NF gene and are age dependent, suggesting a number of similarities with cytoskeletal perturbations that occur in the human nervous system due to aging and diseases associated with aging. Inappropriate processing, degradation, and/or overproduction of the human NF protein in the transgenie mice may be possible mechanisms leading to cytoskeletal alterations. Indeed, relatively young transgenic mice expressing high levels (two to four times the level of the endogenous subunit) of either human NF-H (C&t et al., 1993) or the endogenous NF-L proteins have been shown to develop accumulations of NFs in spinal motor neurons that resemble the pathologic features of human motor neuron disease. However, in NF(M)27 mice, gross overexpression of NF protein may be unlikely to be the cause of NFA formation since the transgenic human NF-M was shown to be present at very low levels (2-25%) relative to the level of the endogenous murine NF-M . The brain areas showing these neurofilamentous changes were among those that were previously demonstrated to contain relatively higher amounts of the human NF-M protein (12-25% of the endogenous NF-M), whereas no NFAs were detected in the spinal cord, which appears to contain little human NF-M (approximately 2-3% of the endogenous NF-M). Future studies will examine whether there may be an age-related upregulation of human NF-M expression or an increase in protein levels that may account for the accumulation of NFs in these neurons. Conversely, there is a large body of evidence demonstrating age-related changes in neurofilaments in the human nervous system, suggesting that species-specific characteristics of the human NF protein in this transgenic line may cause heightened susceptibility to age-related cellular processes that in turn lead to alterations in the normal neurofilamentous cytoskeleton. Interestingly, while many of the older transgenic animals showed these neurofilamentous changes, the relative density of the NFAs varied between animals of the same age, which may be indicative of the complex age-related mechanisms that affect neurons. Similarly, Alzheimer's disease-like pathology appears to be selective for certain subpopulations of neurons and affects particular cytoskeletal proteins, and yet there is great variability in the distribution of the neurofibrillary pathology that occurs during normal human aging (Bouras et al., 1993) and Alzheimer's disease (Arnold et al., 199 1) .
Many of the NFAs in the transgenic animals also closely resembled, both ultrastructurally and immunohistochemically, similar filamentous inclusions that occur in animal models of aluminum toxicity (Terry and Pena, 1965; Dahl and Bignami, 1978; Kowall et al., 1989; Gilbert et al., 1992) . Notably, neocortical pyramidal neurons in layers III and V were selectively vulnerable to form tangle-like NFAs in both the transgenic animals and aluminum-intoxicated rabbits (Kowall et al., 1989) . However, these rabbit filamentous inclusions contained phosphorylation-dependent NF epitopes, whereas the tangle-like NFAs in NF(M)27 mice lacked such epitopes.
Is pathologic heterogeneity in NF(M)27 mice related to cell-type-specific processing of NFs? There is increasing evidence that different subpopulations of neurons contain and regulate the intermediate filament protein component of their cytoskeleton differentially. A number of different proteins can comprise mammalian neuronal intermediate filaments, including the three related proteins known as the NF triplet as well as the 66 kDa protein a-internexin (Pachter and Liem, 1985; Chiu et al., 1989 ) and the 57 kDa protein peripherin (Portier et al., 1984; Leonard et al., 1988; Parysek and Goldman, 1988) . The NF triplet subunits are largely coexpressed (Shaw, 1991) are likely to be obligatory heteropolymers (Lee et al., 1993) , and are present in specific subpopulations of neurons throughout the nervous system, which can vary or be conserved in homologous groups of neurons among mammalian species (reviewed in Vickers and Costa, 1992a) . Biochemical studies have even shown differences in NF triplet content in the ventral tegmental area between strains of rats (Guitar-t et al., 1992) . Neuron-specific molecular heterogeneity of neuronal intermediate filaments can also occur. For example, for most NF tripletxontaining neurons, phosphorylation of the carboxy terminal domain of NF-M and NF-H occurs in the axon. However, different neuronal subpopulations can vary in the degree to which their axonal NFs are phosphorylated (Oblinger et al., 1988; Szaro et al., 1990) , and specific subgroups of neurons in sympathetic ganglia (Vickers and Costa, 1992b) , retina (Shaw and Weber, 1984; Vickers and Costa, 1992a; Peichl and Gonzalez-Soriano, 1993 ) peripheral sensory ganglia (Lawson et al., 1984; Berglund and Ryugo, 1986; Romand et al., 1988; Vickers and Costa, 199 l) , the mesencephalic sensory ganglion of the trigeminal nerve (Poltarak and Freed, 1987) , and septofimbrial and triangular septal nuclei (Klosen et al., 1992) have been shown to contain phosphorylated NF epitopes in their cell body that are commonly found in axons. In addition, specific epitopes linked to the conformation of the extreme carboxyterminal domain of NF-M are differentially present in cell body and axonal domains of particular NF triplet-containing neurons (Vickers et al., 1990; Harris et al., 1991; Vickers and Costa, 1992a,b; Eaker et al., 1993) . These studies indicate a remarkable specificity in distribution and regulation of neuronal intermediate filament proteins that is consistent with the view that the neurofilamentous cytoskeleton is more dynamic than previously thought (Steiner? and Liem, 1990; Nixon and Sihag, 1991; Shaw, 1991; Skalli et al., 1992; Vickers and Costa, 1992a; Nixon, 1993) and may have cell-type-specific roles that are dependent on a configuration of both protein content and subsequent modifications. Consistent with this notion are observations that indicate that alterations in NFs can occur as a function of influences on neurons such as deafferentation (Shaw et al., 1988) specific excitatory amino acid receptor agonists (Wang et al., 1992) diabetes (Burnstock et al., 1988) thyroid deficiency (Marc et al., 1986 ) social deprivation (Siegel et al., 1993) morphine and cocaine (BeitnerJohnson et al., 1992) ethanol (Guru et al., 199 l), myelination (de Waegh et al., 1992) and even temperature in the case of poikilothermic vertebrate species (Potter, 1975) . Similarly, the neurofilamentous cytoskeleton may show particular vulnerability to processes associated with aging and related disease processes, although the precise pathologic consequences may be cell-type-specific and depend on how NFs are regulated in each particular neuron type. For example, the selective distribution of the NF triplet to particular cortical neurons has been hypothesized to underlie the vulnerability of neurons to form the neurofibrillary tangle of Alzheimer's disease (Morrison et al., 1987; Hof et al., 1990; Vickers and Costa, 1992a; Vickers et al., 1992) .
The heterogeneous forms of NFAs observed in the transgenic mice may also be due to cell-type-specific regulation of the cytoskeleton, which may indicate why these inclusions are strikingly similar to the specific forms of neurofibrillary pathology observed in different human neurodegenerative diseases. For example, the NF(M)27 mouse line mirrors the selective sensitivity of human neocortical neurons in Alzheimer's disease in that the mouse NF triplet-containing pyramidal neurons in layers III and V were the most vulnerable to form tangle-like NFAs, and these tangles were labeled with an antibody that recognizes nonphosphorylated NF protein, a feature shared with the early transitional form of the human neurofibrillary tangle (Vickers et al., 1992) . In addition, the neurofilamentous aggregations often extended into the apical and basal dendrites, which followed the normal distribution of neurofilament immunoreactivity into these dendritic domains in certain pyramidal cells, and resembled in part the dendritic neurofibrillary pathology that is often associated with tangle formation (Braak and Braak, 1988) . However, the tangle-like NFAs in these mice differed from neurofibrillary tangles in Alzheimer's disease in many respects. Anatomical discrepancies exist in terms of the relatively few tangle-like NFAs observed in the entorhinal cortex of the older NF(M)27 mice, which is one of the earliest and most devastated sites of neurofibrillary pathology in Alzheimer's disease (Vickers et al., 1992) . Mouse tangle-like NFAs were also unlabeled with thioflavine S or antibodies to ubiquitin and the neurofibrillary tangle marker, Alz50. Neurofibrillary tangles found in humans may have undergone further maturation than those represented in NF(M)27 mice. Further studies will determine whether the mouse tangle-like NFAs may lead to alterations of mouse tau proteins, and the degree to which specific experimental manipulations can lead to the formation of the NFAs in the transgenic mice that mirror the human pathologic profiles more precisely.
The NF(M)27 mouse line may also serve as a model for, and provide some insight into, dementing disorders other than Alzheimer's disease. For example, both Pick's disease and Lewy body-type dementias are characterized by the presence of spherical inclusion bodies that occur within cortical layers that contain nonpyramidal and small pyramidal neurons, and the Pick and Lewy bodies are composed of filamentous material that can be labeled with NF antibodies (Sima et al., 1986; Dickson et al., 1987; G. Perry et al., 1987; Ulrich et al., 1987; R. H. Perry et al., 1990; Schmidt et al., 199 1; Pollanen et al., 1992) . The spherical NFAs that occur in the NF(M)27 mouse line are therefore very similar in their laminar location, morphology, and neurofibrillary ultrastructure to both the cortical Lewy body and Pick body. In addition, the spherical NFAs of the transgenic mice and the Pick bodies in pathological human specimens both predominate in frontal cortex. Interestingly, the spherical NFAs were localized to cortical layers that usually lack NF tripletcontaining neurons (Vickers and Costa, 1992a) , and mouse NF proteins were also immunohistochemically detected in these cortical NFAs. Induction of mouse NF protein expression in these cells may represent a response to human NF expression, a phenomenon previously noted for models of keratin expression in transfected cells (Giudice and Fuchs, 1987) . The presence of NF triplet subunits in the cortical neurons that normally do not contain, or contain low amounts of, these proteins may therefore be a causative factor leading to the formation of the spherical NFAs within perikarya, indicating a possible pathway by which the cortical spherical inclusions present in human diseases may occur. Thus, induction or misprocessing of NF triplet proteins in some of the neurons that are not normally equipped to incorporate such proteins into their cytoskeleton and/or transport them into more distal processes may finally result in an accumulation of NFs and interconnected cytoskeleta1 elements in the cell body.
The alterations in NFs observed in the cerebellum indicate a further cell-type-specific perturbation of the cytoskeleton. A small minority of Purkinje cells were observed to have intraperikaryal accumulations and/or distentions of the proximal axon, which could be further distinguished by their differential labeling with antibodies that recognize phosphorylation-dependent epitopes. No other neuronal cell type was observed to have such axonal changes. The Purkinje cell axonal NFAs are very similar to the NF-containing, proximal axonal distention known as the "torpedo" (Hirano, 199 1) that has been observed in numerous diseases involving cerebellar degeneration. These accumulations may therefore represent a Purkinje cell-specific consequence of neurofilament perturbation.
Abnormal phosphorylation of NFs has been linked with the formation of the filamentous hallmarks of numerous human neurodegenerative diseases. Thus, phosphorylation of the human NF-M subunit beyond that of murine NF-M may play a role in the development of NFAs in the transgenic mice. The torpedo-like axonal swellings in the cerebellum and the spherical NFAs of the cortex were labeled with phosphorylation-dependent NF antibodies. Ultrastructurally, the cortical spherical NFAs were shown to be composed of bundles of NFs with fine crosslinks. This ordered appearance is very similar to that normally observed for NFs in axons and it will be important to pursue the possibility that this organization may be related to the phosphorylation state of the NF subunits. However, most of the cortical tangle-like NFAs and subcortical perikaryal NFAs did not contain an immunodetectable increase in phosphorylation of either the human or mouse NF subunits. Detailed investigation of early stages of NFA formation may clarify the role of phosphorylation in the development of these NFAs. Recently, it has been proposed that neurofibrillary tangle formation in Alzheimer's disease involves the initial alteration of perikaryal nonphosphorylated NF proteins followed by the further trans- 5610 Vickers et al. l Neurofilamentous Alterations i n Transgenic Mice formation of these filaments into pathological structures, which is, in turn, associated with phosphorylation (Vickers et al., 1992) . Thus, NFAs in the transgenic mice and the human neurofibrillary pathologic structures involving NFs may result from an initial perturbation in the normal neurofilamentous cytoskeleton followed in some cases by abnormal phosphorylation.
Conclusions
The presence and heterogeneity of NFA formation in the older NF(M)27 mice may be linked to an interaction between agingrelated cellular processes and the specific molecular features of human NF-M, as well as to the different ways in which specific neuronal subpopulations regulate their cytoskeleton, and may in turn indicate similar mechanisms that may be occurring in human degenerative diseases. This may be particularly important in the context of the plasticity of these cytoskeletal elements and the possible reversibility of neurofilamentous changes, as demonstrated in models of aluminum-mediated neurofilamentous accumulations (Gilbert et al., 1992) . Indeed, our doublelabeling experiments suggest that many of the NFAs observed in the transgenic mice were found in otherwise intact cells, which is very similar to the observations that the transitional forms of the human neurofibrillary tangle are largely intracellular as well (Vickers et al., 1992) . This transgenic animal model may also be utilized to elaborate the consequences of such pathological changes in NFs for cellular function, neural circuitry, and behavior.
